PGL3
MCID: PRG020
MIFTS: 38

Paragangliomas 3 (PGL3)

Categories: Cancer diseases, Ear diseases, Endocrine diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Paragangliomas 3

MalaCards integrated aliases for Paragangliomas 3:

Name: Paragangliomas 3 56 52 73 29 13 6 71
Pgl3 56 52 73
Glomus Tumors, Familial, 3 56 52
Sdhc-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome 52
Familial Non-Chromaffin Paragangliomas 3 73
Glomus Tumors Familial 3 73
Paragangliomas, Type 3 39

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant

Miscellaneous:
signs and symptoms depend on tumor location and activity
see also pgl1
cells of origin are part of the diffuse neuroendocrine system (dnes)
adult onset, wide range of age


HPO:

31
paragangliomas 3:
Inheritance autosomal dominant inheritance
Onset and clinical course adult onset


Classifications:



Summaries for Paragangliomas 3

UniProtKB/Swiss-Prot : 73 Paragangliomas 3: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear.

MalaCards based summary : Paragangliomas 3, also known as pgl3, is related to hereditary paraganglioma-pheochromocytoma syndromes and paragangliomas 4, and has symptoms including aphonia An important gene associated with Paragangliomas 3 is SDHC (Succinate Dehydrogenase Complex Subunit C). Affiliated tissues include prostate, liver and lung, and related phenotypes are hyperhidrosis and cranial nerve paralysis

More information from OMIM: 605373 PS168000

Related Diseases for Paragangliomas 3

Diseases in the Paraganglioma family:

Paragangliomas 4 Paragangliomas 1
Paragangliomas 2 Paragangliomas 3
Paragangliomas 5 Paragangliomas 6
Paragangliomas 7 Nonsyndromic Paraganglioma

Diseases related to Paragangliomas 3 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 hereditary paraganglioma-pheochromocytoma syndromes 11.4
2 paragangliomas 4 10.2
3 paragangliomas 1 10.2
4 paragangliomas 2 10.2
5 posttransplant acute limbic encephalitis 10.2
6 paraganglioma 9.8
7 pelizaeus-merzbacher disease 9.4 SDHC MPZ
8 charcot-marie-tooth disease 9.2 SDHC MPZ

Graphical network of the top 20 diseases related to Paragangliomas 3:



Diseases related to Paragangliomas 3

Symptoms & Phenotypes for Paragangliomas 3

Human phenotypes related to Paragangliomas 3:

31 (show all 16)
# Description HPO Frequency HPO Source Accession
1 hyperhidrosis 31 HP:0000975
2 cranial nerve paralysis 31 HP:0006824
3 vocal cord paralysis 31 HP:0001605
4 hoarse voice 31 HP:0001609
5 tachycardia 31 HP:0001649
6 palpitations 31 HP:0001962
7 recurrent paroxysmal headache 31 HP:0002331
8 hypertension associated with pheochromocytoma 31 HP:0002640
9 adrenal pheochromocytoma 31 HP:0006748
10 extraadrenal pheochromocytoma 31 HP:0006737
11 episodic paroxysmal anxiety 31 HP:0000740
12 pulsatile tinnitus 31 HP:0008629
13 loss of voice 31 HP:0001686
14 glomus jugular tumor 31 HP:0003001
15 chemodectoma 31 HP:0030074
16 elevated circulating catecholamine level 31 HP:0003334

Symptoms via clinical synopsis from OMIM:

56
Voice:
loss of voice
hoarse voice (caused by tumor impingement)

Cardiovascular Heart:
palpitations (with pheochromocytoma)
tachycardia (with pheochromocytoma)

Skin Nails Hair Skin:
diaphoresis (with pheochromocytoma)

Neurologic Behavioral Psychiatric Manifestations:
anxiety (with pheochromocytoma)

Respiratory Larynx:
vocal cord paralysis (caused by tumor impingement)

Head And Neck Ears:
pulsatile tinnitus (tympanic paraganglioma)

Cardiovascular Vascular:
hypertension (with pheochromocytoma)

Neurologic Central Nervous System:
headache (with pheochromocytoma)
cranial nerve palsies can arise with head and neck paragangliomas

Neoplasia:
paragangliomas
chemodectomas
carotid body tumors
glomus jugular tumors
multiple tumors
more
Laboratory Abnormalities:
elevated catecholamines (in patients with pheochromocytoma)

Clinical features from OMIM:

605373

UMLS symptoms related to Paragangliomas 3:


aphonia

Drugs & Therapeutics for Paragangliomas 3

Search Clinical Trials , NIH Clinical Center for Paragangliomas 3

Genetic Tests for Paragangliomas 3

Genetic tests related to Paragangliomas 3:

# Genetic test Affiliating Genes
1 Paragangliomas 3 29 SDHC

Anatomical Context for Paragangliomas 3

MalaCards organs/tissues related to Paragangliomas 3:

40
Prostate, Liver, Lung, Endothelial, Bone, Breast, Smooth Muscle

Publications for Paragangliomas 3

Articles related to Paragangliomas 3:

(show top 50) (show all 760)
# Title Authors PMID Year
1
An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. 56 6
15342702 2004
2
Mutations in SDHC cause autosomal dominant paraganglioma, type 3. 56 6
11062460 2000
3
Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. 61 6
12658451 2003
4
Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma. 61 56
11426453 2001
5
PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma. 61 56
10541590 1999
6
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 6
27854360 2017
7
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 6
25356965 2015
8
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 6
25394175 2015
9
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 6
24893135 2014
10
Canadian guideline on genetic screening for hereditary renal cell cancers. 6
24319509 2013
11
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 6
23788249 2013
12
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. 56
21348866 2012
13
Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer. 6
20816580 2010
14
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. 6
20065170 2010
15
Hereditary Paraganglioma-Pheochromocytoma Syndromes 6
20301715 2008
16
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. 56
16249420 2005
17
Association of human serotonin receptor 4 promoter methylation with autism spectrum disorder. 61
31977880 2020
18
Analysis of potential redundancy among Arabidopsis 6-phosphogluconolactonase isoforms in peroxisomes. 61
31641750 2020
19
Fe3+-Coordinated Multifunctional Elastic Nanoplatform for Effective in Vivo Gene Transfection. 61
31895537 2020
20
Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells. 61
31638218 2019
21
A 14-bp functional deletion within the CMTM2 gene is significantly associated with litter size in goat. 61
31362196 2019
22
Grass carp (Ctenopharyngodon idella) NRF2 alleviates the oxidative stress and enhances cell viability through upregulating the expression of HO-1. 61
31758371 2019
23
miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway. 61
31538414 2019
24
The A allele of the UCP2 -866G/A polymorphism changes UCP2 promoter activity in HUVECs treated with high glucose. 61
31218541 2019
25
Transcription Factor CEBPB Inhibits the Expression of the Human HTR1A by Binding to 5' Regulatory Region in Vitro. 61
31614865 2019
26
[ADRB2 Gene Knockout in Human Primary T Cells by Multiple sgRNAs Construced using CRISPR/Cas9 Technology]. 61
31607332 2019
27
Significant association of EED promoter hypomethylation with colorectal cancer. 61
31423224 2019
28
Transcriptional regulation of the porcine miR-17-92 cluster. 61
30972482 2019
29
MiR-145 protected the cell viability of human cerebral cortical neurons after oxygen-glucose deprivation by downregulating EPHA4. 61
31150684 2019
30
Relationship between porcine miR-20a and its putative target low-density lipoprotein receptor based on dual luciferase reporter gene assays. 61
30744358 2019
31
Nuclear delivery of plasmid DNA determines the efficiency of gene expression. 61
31042002 2019
32
Androgenic/antiandrogenic activities of PAEs determined by a novel AR-mediated reporter gene assay based on LLC-MK2 cells. 61
31367335 2019
33
[Cloning of New Antigen Gene MLAA-34 Promoter and Identification of Core Region in Acute Monocytic Leukemia]. 61
31204911 2019
34
Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs. 61
30913089 2019
35
Identification of a promoter element mediating kisspeptin-induced increases in GnRH gene expression in sheep. 61
30853631 2019
36
The Flavonoid Quercetin Induces AP-1 Activation in FRTL-5 Thyroid Cells. 61
31035637 2019
37
Immobilization of plasmids in bacterial nanocellulose as gene activated matrix. 61
30732826 2019
38
Characterization of the human mucin 5AC promoter and its regulation by the histone acetyltransferase P300. 61
30628655 2019
39
Elovl4a participates in LC-PUFA biosynthesis and is regulated by PPARαβ in golden pompano Trachinotus ovatus (Linnaeus 1758). 61
30886313 2019
40
Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese. 61
30638951 2019
41
Transcriptional Regulation of NAMPT Gene by Glycogen Synthase Kinase 3β in Goat Adipocytes. 61
30615481 2019
42
Insecticides induce the co-expression of glutathione S-transferases through ROS/CncC pathway in Spodoptera exigua. 61
30857628 2019
43
[Ubiquitin specific peptidase 22 regulates the transcription activity of mitogen-activated protein kinase kinase 6 gene]. 61
30837379 2019
44
Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1. 61
30506548 2019
45
Identification of a Novel Functional Corticotropin-Releasing Hormone (CRH2) in Chickens and Its Roles in Stimulating Pituitary TSHβ Expression and ACTH Secretion. 61
31555213 2019
46
Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter. 61
31827541 2019
47
Novel lncRNA lncFAM200B: Molecular Characteristics and Effects of Genetic Variants on Promoter Activity and Cattle Body Measurement Traits. 61
31649734 2019
48
Identification of the minimum region of flatfish myostatin propeptide (Pep45-65) for myostatin inhibition and its potential to enhance muscle growth and performance in animals. 61
30998775 2019
49
Characterization and functional analyses of the human HTR1A gene: 5' regulatory region modulates gene expression in vitro. 61
30594152 2018
50
MiRNA-199a-5p positively regulated RANKL-induced osteoclast differentiation by target Mafb protein. 61
30387167 2018

Variations for Paragangliomas 3

ClinVar genetic disease variations for Paragangliomas 3:

6 (show top 50) (show all 154) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 SDHC NM_003001.3(SDHC):c.397C>T (p.Arg133Ter)SNV Pathogenic 183753 rs764575966 1:161326622-161326622 1:161356832-161356832
2 SDHC NM_003001.3(SDHC):c.3G>A (p.Met1Ile)SNV Pathogenic 7241 rs587776652 1:161284198-161284198 1:161314408-161314408
3 SDHC SDHC, 8,372-BP DELdeletion Pathogenic 7243
4 SDHC NM_003001.3(SDHC):c.406-?_*2318+?deldeletion Pathogenic 239456
5 SDHC NM_003001.3(SDHC):c.43C>T (p.Arg15Ter)SNV Pathogenic 41776 rs201286421 1:161293426-161293426 1:161323636-161323636
6 SDHC NC_000001.10:g.(?_161326467)_(161326630_?)deldeletion Pathogenic 417389 1:161326467-161326630 1:161356677-161356840
7 SDHC NM_003001.3(SDHC):c.1A>G (p.Met1Val)SNV Pathogenic 407060 rs755235380 1:161284196-161284196 1:161314406-161314406
8 SDHC NC_000001.10:g.(?_161284190)_(161332229_?)deldeletion Pathogenic 534384 1:161284190-161332229 1:161314400-161362439
9 deletion Pathogenic 559476
10 SDHC NM_003001.3(SDHC):c.215del (p.Arg72fs)deletion Pathogenic 534368 rs1553264218 1:161310419-161310419 1:161340629-161340629
11 SDHC NC_000001.10:g.(?_161326457)_(161332233_?)deldeletion Pathogenic 650709 1:161326457-161332233 1:161356667-161362443
12 SDHC NC_000001.10:g.(?_161326457)_(161326640_?)deldeletion Pathogenic 644840 1:161326457-161326640 1:161356667-161356850
13 SDHC NM_003001.3(SDHC):c.405+1G>CSNV Pathogenic/Likely pathogenic 428934 rs587776653 1:161326631-161326631 1:161356841-161356841
14 SDHC NM_003001.3(SDHC):c.405+1G>TSNV Pathogenic/Likely pathogenic 7242 rs587776653 1:161326631-161326631 1:161356841-161356841
15 SDHC NC_000001.10:g.(?_161310384)_(161310445_?)dupduplication Likely pathogenic 417394 1:161310384-161310445 1:161340594-161340655
16 SDHC NM_003001.3(SDHC):c.1A>T (p.Met1Leu)SNV Likely pathogenic 653751 1:161284196-161284196 1:161314406-161314406
17 SDHC NM_003001.3(SDHC):c.214C>T (p.Arg72Cys)SNV Likely pathogenic 653952 1:161310418-161310418 1:161340628-161340628
18 SDHC NM_003001.3(SDHC):c.78-1G>TSNV Likely pathogenic 534370 rs786202200 1:161298185-161298185 1:161328395-161328395
19 SDHC NM_003001.3(SDHC):c.405+1deldeletion Likely pathogenic 570507 rs1558182956 1:161326630-161326630 1:161356840-161356840
20 SDHC NM_003001.3(SDHC):c.99G>A (p.Thr33=)SNV Conflicting interpretations of pathogenicity 486428 rs145535502 1:161298207-161298207 1:161328417-161328417
21 SDHC NM_003001.3(SDHC):c.377A>G (p.Tyr126Cys)SNV Conflicting interpretations of pathogenicity 428933 rs898854295 1:161326602-161326602 1:161356812-161356812
22 SDHC NM_003001.3(SDHC):c.224G>A (p.Gly75Asp)SNV Conflicting interpretations of pathogenicity 189841 rs786205147 1:161310428-161310428 1:161340638-161340638
23 SDHC NM_003001.3(SDHC):c.54T>G (p.Phe18Leu)SNV Conflicting interpretations of pathogenicity 232892 rs200761743 1:161293437-161293437 1:161323647-161323647
24 SDHC NM_003001.3(SDHC):c.148C>T (p.Arg50Cys)SNV Conflicting interpretations of pathogenicity 135194 rs587778661 1:161298256-161298256 1:161328466-161328466
25 SDHC NM_003001.3(SDHC):c.380A>G (p.His127Arg)SNV Conflicting interpretations of pathogenicity 187084 rs786203457 1:161326605-161326605 1:161356815-161356815
26 SDHC NM_003001.3(SDHC):c.405+23C>TSNV Conflicting interpretations of pathogenicity 239455 rs373731336 1:161326653-161326653 1:161356863-161356863
27 SDHC NM_003001.3(SDHC):c.398G>A (p.Arg133Gln)SNV Uncertain significance 41775 rs386833414 1:161326623-161326623 1:161356833-161356833
28 SDHC NM_003001.3(SDHC):c.*20T>GSNV Uncertain significance 135195 rs587778662 1:161332243-161332243 1:161362453-161362453
29 SDHC NM_003001.3(SDHC):c.292T>G (p.Ser98Ala)SNV Uncertain significance 141883 rs371462564 1:161326517-161326517 1:161356727-161356727
30 SDHC NM_003001.3(SDHC):c.436C>A (p.Pro146Thr)SNV Uncertain significance 142904 rs541660851 1:161332149-161332149 1:161362359-161362359
31 SDHC NM_003001.3(SDHC):c.226A>G (p.Ile76Val)SNV Uncertain significance 407051 rs1060501389 1:161310430-161310430 1:161340640-161340640
32 SDHC NM_003001.3(SDHC):c.238G>A (p.Ala80Thr)SNV Uncertain significance 407045 rs149375851 1:161310442-161310442 1:161340652-161340652
33 SDHC NM_003001.3(SDHC):c.296A>G (p.Tyr99Cys)SNV Uncertain significance 407052 rs1060501390 1:161326521-161326521 1:161356731-161356731
34 SDHC NM_003001.3(SDHC):c.7G>T (p.Ala3Ser)SNV Uncertain significance 407053 rs748243732 1:161284202-161284202 1:161314412-161314412
35 SDHC NM_003001.3(SDHC):c.11T>C (p.Leu4Pro)SNV Uncertain significance 371802 rs774299337 1:161284206-161284206 1:161314416-161314416
36 SDHC NM_003001.3(SDHC):c.197C>T (p.Ala66Val)SNV Uncertain significance 371843 rs760572684 1:161310401-161310401 1:161340611-161340611
37 SDHC NC_000001.10:g.(?_161293404)_(161293460_?)deldeletion Uncertain significance 417395 1:161293404-161293460 1:161323614-161323670
38 SDHC NM_001035511.2(SDHC):c.8C>T (p.Ala3Val)SNV Uncertain significance 161387 rs142139022 1:161284203-161284203 1:161314413-161314413
39 SDHC NM_003001.3(SDHC):c.15G>T (p.Leu5Phe)SNV Uncertain significance 184591 rs771746264 1:161284210-161284210 1:161314420-161314420
40 SDHC NM_003001.3(SDHC):c.32G>T (p.Arg11Leu)SNV Uncertain significance 187333 rs767802663 1:161293415-161293415 1:161323625-161323625
41 SDHC NM_003001.3(SDHC):c.25G>A (p.Val9Ile)SNV Uncertain significance 239451 rs774768866 1:161293408-161293408 1:161323618-161323618
42 SDHC NM_003001.3(SDHC):c.32G>A (p.Arg11His)SNV Uncertain significance 239454 rs767802663 1:161293415-161293415 1:161323625-161323625
43 SDHC NM_003001.3(SDHC):c.73A>G (p.Arg25Gly)SNV Uncertain significance 239457 rs878854587 1:161293456-161293456 1:161323666-161323666
44 SDHC NM_003001.3(SDHC):c.85C>G (p.Pro29Ala)SNV Uncertain significance 239458 rs878854588 1:161298193-161298193 1:161328403-161328403
45 SDHC NM_003001.3(SDHC):c.119G>A (p.Arg40Gln)SNV Uncertain significance 239446 rs772450693 1:161298227-161298227 1:161328437-161328437
46 SDHC NM_003001.3(SDHC):c.128A>G (p.Asn43Ser)SNV Uncertain significance 239448 rs747349777 1:161298236-161298236 1:161328446-161328446
47 SDHC NM_003001.3(SDHC):c.164A>G (p.His55Arg)SNV Uncertain significance 239449 rs878854585 1:161298272-161298272 1:161328482-161328482
48 SDHC NM_003001.3(SDHC):c.295T>C (p.Tyr99His)SNV Uncertain significance 239453 rs760678574 1:161326520-161326520 1:161356730-161356730
49 SDHC NM_003001.3(SDHC):c.432G>T (p.Lys144Asn)SNV Uncertain significance 465974 rs1366410028 1:161332145-161332145 1:161362355-161362355
50 SDHC NM_003001.3(SDHC):c.22C>T (p.His8Tyr)SNV Uncertain significance 465965 rs746666691 1:161293405-161293405 1:161323615-161323615

Expression for Paragangliomas 3

Search GEO for disease gene expression data for Paragangliomas 3.

Pathways for Paragangliomas 3

GO Terms for Paragangliomas 3

Sources for Paragangliomas 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....